Protesters Target GSK Over HIV Drug Patent

Law360, New York (August 7, 2006, 12:00 AM EDT) -- Protests have erupted in Thailand as its government prepares to grant a patent to British drug maker GlaxoSmithKline for a popular HIV treatment, despite the fact that an appeal over patentability hasn’t yet been ruled on.

Hundreds of Thai demonstrators, many of them living with HIV/AIDS, staged a noisy protest at GSK’s headquarters in Bangkok, arguing that an increase in the cost of the anti-retroviral will threaten lives.

In the world of generic drugs, such arguments are hardly new. But the activists’ complaints have transcended moral...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.